FDA Adverse Event Malfunction Summary report: N

ANALYTICAL E MODULE

MDR report key: 2477866 · Received March 5, 2012

Report

Report Number
1823260-2012-01229
Event Type
Malfunction
Date Received
March 5, 2012
Date of Event
February 10, 2012
Report Date
May 30, 2012
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LTJ
PMA / PMN Number
K961481
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION COULD NOT DETERMINE A SPECIFIC ROOT CAUSE. THE PROVIDED CALIBRATION, QUALITY CONTROL AND PERFORMANCE TESTING DATA DID NOT INDICATE ANY REAGENT OR SYSTEM ISSUE. THE RESULTS WERE NOT REPRODUCIBLE. THE PATIENT WAS NOT HARMED BY ANY ACTION TAKEN.

Additional Manufacturer Narrative · 1

THE TOTAL PSA REAGENT LOT NUMBER WAS 163492. THE FREE PSA REAGENT LOT NUMBER WAS 165433.

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE USER RECEIVED QUESTIONABLE TOTAL PSA (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TOTAL PSA) AND FREE PSA RESULTS FOR ONE SAMPLE FROM A PATIENT BORN IN (B)(6). THE INITIAL RESULTS FROM A SAMPLE IN A CUP PROCESSED BY THE MODULAR PREANALYTIC SYSTEM (MPA) WERE A TOTAL PSA OF 7.29 NG/ML AND A FREE PSA OF 4.54 NG/ML. THESE RESULTS WERE REPORTED OUTSIDE THE LABORATORY. ON (B)(6) 2012, THE SAME SAMPLE WAS RETESTED AND THE TOTAL PSA RESULT WAS 1.2 NG/ML AND THE FREE PSA RESULT WAS 0.24 NG/ML. ON (B)(6) 2012, A NEW SAMPLE FROM THE SAME PATIENT WAS TESTED AND THE TOTAL PSA RESULT WAS 1.08 NG/ML AND THE FREE PSA RESULT WAS 0.213 NG/ML. THE PATIENT WAS NOT ADVERSELY AFFECTED. THE TOTAL PSA AND FREE PSA REAGENT LOT NUMBERS AND EXPIRATION DATES WERE NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ANALYTICAL E MODULE IMMUNOCHEMISTRY ANALYZER LTJ ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 064 YR